MARK S SMITH, P.T., A.T.,C.
Athletic Trainer at Kenrick Plz, Saint Louis, MO

License number

Missouri MO 01472

Professional information

General Manager At Peacock Printing, Inc.

Position:

General Manager at Peacock Printing. Inc., General Manager at Peacock Printing, Inc.

Location:

Greater St. Louis Area

Industry:

Printing

Work:

Peacock Printing. Inc. since Jan 2002 - General Manager Peacock Printing, Inc. - Mount Vernon, IL since Jan 2002 - General Manager

Interests:

business management ,marketing, family, hunting, fishing

Honor & Awards:

Superior Achievement in Print Shop Management Eagle Award Exceptional Performance in Print Shop Management Award Outstanding Achievement in Print Shop Growth Award, 2011" Best of the Best" Commercial Printing Dale Carnege course graduate

Information Technology And Services Professional

Location:

Greater St. Louis Area

Industry:

Information Technology and Services

Work:

IBM Jan 1993 - Apr 2009 - Systems Integrator Senior McDonnell Douglas Corporation Nov 1992 - Jan 1993 - Principal Specialist _ Systems Programming Electronic Data Systems Apr 1991 - Nov 1992 - Systems Engineer Advanced - Resource Management

Education:

Missouri State University 1974 - 1978
B.S., Data Processing in Business

Managing Director At Krauter &Amp; Company

Position:

Managing Director at Krauter & Company

Location:

Greater St. Louis Area

Industry:

Insurance

Work:

Krauter & Company - Managing Director

Ramp Agent At Us Airways

Position:

ramp agent at US Airways

Location:

Greater St. Louis Area

Industry:

Airlines/Aviation

Work:

US Airways - ramp agent

Computer Guy At Webster

Position:

computer guy at webster

Location:

Greater St. Louis Area

Industry:

Computer & Network Security

Work:

webster - computer guy

Combinations Of Ileal Bile Acid Transport Inhibitors And Cholesteryl Ester Transfer Protein Inhibitors For Cardiovascular Indications

US Patent:

6458851, Oct 1, 2002

Filed:

Dec 17, 1999

Appl. No.:

09/466415

Inventors:

Bradley T. Keller - Chesterfield MO
James A. Sikorski - Des Peres MO
Kevin C. Glenn - Maryland Heights MO
Daniel T. Connolly - Ballwin MO
Mark E. Smith - Webster Groves MO
Joseph R. Schuh - St. Louis MO

Assignee:

G. D. Searle, LLC - Chicago IL

International Classification:

A61K 314995

US Classification:

514655, 51425213, 514718, 514741, 514824, 514431, 424451, 424464

Abstract:

The present invention provides combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. Combinations disclosed include an ileal bile acid transport inhibitor combined with a cholesteryl ester transfer protein (CETP) inhibitor.

Combinations Of Cholesteryl Ester Transfer Protein Inhibitors And Hmg Coa Reductase Inhibitors For Cardiovascular Indications

US Patent:

6462091, Oct 8, 2002

Filed:

Dec 17, 1999

Appl. No.:

09/466414

Inventors:

Bradley T. Keller - Chesterfield MO
James A. Sikorski - Des Peres MO
Kevin C. Glenn - Maryland Heights MO
Daniel T. Connolly - Ballwin MO
Mark E. Smith - Webster Groves MO

Assignee:

G.D. Searle Co. - Chicago IL

International Classification:

A61K 31136

US Classification:

514655, 514718, 514741, 514546, 514824, 424451, 424464

Abstract:

The present invention provides combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. Combinations disclosed include an HMG CoA reductase inhibitor combined with a cholesteryl ester transfer protein (CETP) inhibitor.

Combinations Of Cholesterol Ester Transfer Protein Inhibitors And Hmg Coa Reductase Inhibitors For Cardiovascular Indications

US Patent:

2007020, Aug 30, 2007

Filed:

May 1, 2007

Appl. No.:

11/742764

Inventors:

Bradley Keller - Chesterfield MO, US
James Sikorski - Des Peres MO, US
Kevin Glenn - Maryland Heights MO, US
Daniel Connolly - Ballwin MO, US
Mark Smith - Webster Groves MO, US

International Classification:

A61K 31/135

US Classification:

514646000

Abstract:

The present invention provides combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. Combinations disclosed include an HMG CoA reductase inhibitor combined with a cholesteryl ester transfer protein (CETP) inhibitor.